Psoriasis
☆ Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
Pada ati apa eniyan ti o ni psoriasis
psoriasis aṣoju
Guttate Psoriasis
References
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).
Awọn itọju oriṣiriṣi le ṣe iranlọwọ lati ṣakoso awọn aami aisan naa. Awọn itọju wọnyi pẹlu awọn ipara sitẹriọdu, ipara Vitamin D3, ina ultraviolet, ati awọn oogun ajẹsara, gẹgẹbi methotrexate. Nipa 75% ti ilowosi awọ ara dara si pẹlu awọn ipara nikan. Orisirisi awọn aṣoju ajẹsara ti ara ti wa ni idagbasoke fun itọju psoriasis.
Psoriasis jẹ rudurudu ti o wọpọ ati pe arun na kan 2-4% ti olugbe. Awọn ọkunrin ati awọn obinrin ni o ni ipa pẹlu igbohunsafẹfẹ dogba. Arun le bẹrẹ ni eyikeyi ọjọ ori, ṣugbọn igbagbogbo bẹrẹ ni agbalagba. Arthritis Psoriatic yoo kan to 30% ti awọn ẹni-kọọkan pẹlu psoriasis.
○ Itọju - Oògùn OTC
Imọlẹ oorun le ṣe iranlọwọ fun psoriasis nitori ifihan oorun nfa awọn ayipada ajẹsara ninu awọn alaisan pẹlu psoriasis. Ikunra ikunra hydrocortisone kekere le ṣe iranlọwọ lati tọju diẹ ninu awọn egbo kekere ti psoriasis.
#OTC steroid ointment
○ Itọju
Psoriasis jẹ arun onibaje ati pe ọpọlọpọ awọn aṣoju itọju ti wa ni iwadi. Biologics ni o munadoko julọ ṣugbọn gbowolori pupọ.
#High potency steroid ointment
#Calcipotriol cream
#Phototherapy
#Biologics (e.g. infliximab, adalimumab, secukinumab, ustekinumab)